We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Verdezyne Signs R&D Agreement for Novel Enzymes Gene Development with Syngenta

News   Feb 10, 2009

 
Verdezyne Signs R&D Agreement for Novel Enzymes Gene Development with Syngenta
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Blood Test for Detecting Pre-symptomatic Alzheimer's Disease is Refined

News

A research team have developed a method to detect the amyloid-beta (Aβ) peptide in human blood. They hope that their research will have implications in diagnosing and understanding the progression of Alzheimer's disease (AD).

READ MORE

New Biomarker for Personalized Treatments Against Cancer

News

Scientists have demonstrated that the protein TP53INP2 plays an important role in the induction of cell death. This finding could be relevant in the treatment of certain types of cancer.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE